KREITZER ANATOL (Chief Discovery Officer) received a stock award from MAPLIGHT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/28/2025ACC: 0002021238-25-000006
Officer· Chief Discovery Officer
Since Feb 2026
+182K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
182K acquired
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
+35.95K
Price / share
—
Trade value
—
% of position
New position
10/27/2025
0.00→35.95K
Total
Net shares
+35.95K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 10/27/2025 | A · Award | +35.95K | — | — | New position | 0.00 | 35.95K |
| Total | +35.95K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Voting Common Stock
146.05K shares
Shares
+146.05K
Strike price
17
Held after
146.05K
Exercisable
—
10/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Voting Common Stock146.05K shares | 10/27/2025 | A · Award | +146.05K | 17 | — | 146.05K |